Drug intelligence / Profile preview

latrunculin a

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal (preclinical/animal Studies)
01

Overview

Latrunculin A is a naturally occurring macrolide toxin isolated from the Red Sea sponge *Latrunculia magnifica* and other marine sponges. It acts as a potent inhibitor of actin polymerization by binding monomeric G-actin in a 1:1 stoichiometry with high affinity (Kd ≈ 0.2 µM), thereby preventing the formation of F-actin filaments and disrupting microfilament organization within cells[1][2][5][6]. This disruption leads to reversible morphological changes in mammalian cells and impairs cellular processes dependent on actin dynamics such as cell division and phagocytosis[7]. Latrunculin A has been widely used as a research tool to study cytoskeletal function and is under investigation for its potential anticancer properties due to its ability to inhibit mitotic spindle formation and cell replication[1][3][4].

Other names
(+)-latrunculin A(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one76343–93–6
02

Targets

Actin filament proteins

Beyond the preview

Go deeper on latrunculin a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on latrunculin a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call